Emory University as of June 30, 2019
Portfolio Holdings for Emory University
Emory University holds 46 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Berkshire Hathaway Inc Del Cl A (BRK.A) | 26.2 | $37M | 117.00 | 318350.43 | |
| JD Spon Adr Cl A (JD) | 8.5 | $12M | 398k | 30.29 | |
| Array BioPharma | 2.8 | $4.0M | 87k | 46.33 | |
| Iovance Biotherapeutics (IOVA) | 2.3 | $3.2M | 131k | 24.52 | |
| Mirati Therapeutics | 2.2 | $3.2M | 31k | 103.00 | |
| Ra Pharmaceuticals | 2.1 | $2.9M | 98k | 30.07 | |
| Zogenix Com New | 2.0 | $2.9M | 60k | 47.78 | |
| Eidos Therapeutics | 1.8 | $2.6M | 84k | 31.08 | |
| Blueprint Medicines (BPMC) | 1.8 | $2.6M | 28k | 94.33 | |
| Meiragtx Holdings (MGTX) | 1.8 | $2.6M | 96k | 26.88 | |
| Amarin Corp Spons Adr New (AMRN) | 1.8 | $2.6M | 132k | 19.39 | |
| Genomic Health | 1.8 | $2.5M | 43k | 58.16 | |
| Retrophin | 1.7 | $2.5M | 124k | 20.09 | |
| Wave Life Sciences SHS (WVE) | 1.7 | $2.5M | 95k | 26.09 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $2.4M | 29k | 84.42 | |
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $2.4M | 646k | 3.79 | |
| Incyte Corporation (INCY) | 1.7 | $2.4M | 29k | 84.98 | |
| Madrigal Pharmaceuticals (MDGL) | 1.7 | $2.4M | 23k | 104.79 | |
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $2.4M | 90k | 26.73 | |
| Amicus Therapeutics (FOLD) | 1.7 | $2.4M | 193k | 12.48 | |
| Heron Therapeutics (HRTX) | 1.7 | $2.4M | 129k | 18.59 | |
| Alexion Pharmaceuticals | 1.7 | $2.4M | 18k | 130.96 | |
| Seattle Genetics | 1.6 | $2.3M | 34k | 69.21 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $2.3M | 26k | 85.66 | |
| Beigene Sponsored Adr (BGNE) | 1.6 | $2.2M | 18k | 123.94 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 1.5 | $2.1M | 18k | 115.14 | |
| Global Blood Therapeutics In | 1.5 | $2.1M | 39k | 52.61 | |
| Synthorx | 1.4 | $2.0M | 151k | 13.51 | |
| Citigroup Com New (C) | 1.4 | $2.0M | 29k | 70.05 | |
| Cbre Group Cl A (CBRE) | 1.4 | $2.0M | 39k | 51.29 | |
| Seagate Technology SHS | 1.4 | $2.0M | 42k | 47.12 | |
| Bausch Health Companies (BHC) | 1.4 | $2.0M | 78k | 25.22 | |
| Arcosa (ACA) | 1.4 | $2.0M | 52k | 37.64 | |
| Kkr & Co Cl A (KKR) | 1.4 | $1.9M | 77k | 25.27 | |
| Morgan Stanley Com New (MS) | 1.3 | $1.9M | 43k | 43.81 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $1.9M | 86k | 22.00 | |
| Trinity Industries (TRN) | 1.3 | $1.9M | 91k | 20.75 | |
| SLM Corporation (SLM) | 1.3 | $1.9M | 191k | 9.72 | |
| Alliance Data Systems Corporation (BFH) | 1.3 | $1.8M | 13k | 140.16 | |
| Orchard Therapeutics Ads | 1.2 | $1.7M | 123k | 13.99 | |
| Myovant Sciences | 1.1 | $1.6M | 178k | 9.05 | |
| Summit Midstream Partners Com Unit Ltd | 0.5 | $651k | 88k | 7.43 | |
| Home Depot (HD) | 0.3 | $378k | 1.8k | 207.81 | |
| Cocrystal Pharma Com Par | 0.3 | $359k | 153k | 2.35 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.2 | $276k | 942.00 | 292.99 | |
| Inflarx Nv (IFRX) | 0.1 | $185k | 58k | 3.17 |
